QuiVad

Home / Netherlands / Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 3.89% on March 1, 2024. The shaded band is the year shown above.

June 22, 2023 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

92 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 24, 2024GSA Capital Partners LLP0.33%still open
April 17, 2024Millennium International Management LP1.47%still open
April 16, 2024Millennium International Management LP1.35%still open
April 15, 2024Millennium International Management LP1.23%still open
April 12, 2024Millennium International Management LP1.12%still open
April 11, 2024Millennium International Management LP0.99%still open
April 11, 2024GSA Capital Partners LLP0.71%still open
April 10, 2024Millennium International Management LP0.86%still open
April 9, 2024Millennium International Management LP0.74%still open
April 8, 2024Millennium International Management LP0.61%still open
March 21, 2024GSA Capital Partners LLP0.62%still open
March 14, 2024GSA Capital Partners LLP0.53%still open
March 5, 2024Janus Henderson Investors UK Limited0.00%still open
March 4, 2024Janus Henderson Investors UK Limited1.24%still open
March 4, 2024Adage Capital Management L.P.0.00%still open
March 1, 2024Adage Capital Management L.P.0.92%still open
February 29, 2024Adage Capital Management L.P.0.87%still open
February 27, 2024Janus Henderson Investors UK Limited2.97%still open
February 26, 2024Janus Henderson Investors UK Limited2.80%still open
February 26, 2024Adage Capital Management L.P.0.74%still open
February 22, 2024Janus Henderson Investors UK Limited2.72%still open
February 21, 2024Janus Henderson Investors UK Limited2.61%still open
February 13, 2024Janus Henderson Investors UK Limited2.51%still open
February 7, 2024Janus Henderson Investors UK Limited2.39%still open
January 22, 2024Janus Henderson Investors UK Limited2.23%still open
January 18, 2024Janus Henderson Investors UK Limited2.10%still open
January 17, 2024Janus Henderson Investors UK Limited2.02%still open
January 16, 2024Adage Capital Management L.P.0.61%still open
January 9, 2024Janus Henderson Investors UK Limited1.90%still open
January 9, 2024Adage Capital Management L.P.0.54%still open
December 27, 2023Janus Henderson Investors UK Limited1.80%still open
November 14, 2023Janus Henderson Investors UK Limited1.61%still open
November 10, 2023Janus Henderson Investors UK Limited1.52%still open
November 7, 2023Janus Henderson Investors UK Limited1.42%still open
November 2, 2023Janus Henderson Investors UK Limited1.36%still open
October 31, 2023Janus Henderson Investors UK Limited1.20%still open
August 25, 2023Janus Henderson Investors UK Limited1.12%still open
August 22, 2023Janus Henderson Investors UK Limited1.03%still open
August 8, 2023Janus Henderson Investors UK Limited0.94%still open
June 28, 2023Janus Henderson Investors UK Limited0.81%still open
June 26, 2023Janus Henderson Investors UK Limited0.70%still open
June 22, 2023Janus Henderson Investors UK Limited0.59%still open

Other companies sold short in the Netherlands

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Vivoryon Therapeutics N.V., source AFM, data as at February 14, 2025, https://www.quivad.com/action/vivoryon-therapeutics-n-v?page=2